The China Mail - Formerra to Supply Foster Medical Compounds in Europe

USD -
AED 3.673042
AFN 63.503991
ALL 82.403989
AMD 368.150403
ANG 1.790403
AOA 918.000367
ARS 1465.449815
AUD 1.42575
AWG 1.8025
AZN 1.70397
BAM 1.705709
BBD 2.013483
BDT 122.708482
BGN 1.69088
BHD 0.37702
BIF 2985
BMD 1
BND 1.290663
BOB 6.90816
BRL 5.152304
BSD 0.999721
BTN 94.239742
BWP 13.585663
BYN 2.777729
BYR 19600
BZD 2.010527
CAD 1.415225
CDF 2280.000362
CHF 0.807055
CLF 0.02293
CLP 902.460396
CNY 6.769604
CNH 6.783725
COP 3452.68
CRC 453.506829
CUC 1
CUP 26.5
CVE 96.403894
CZK 21.091104
DJF 177.720393
DKK 6.516504
DOP 58.403884
DZD 133.34504
EGP 49.986489
ERN 15
ETB 158.37504
EUR 0.871881
FJD 2.235504
FKP 0.756415
GBP 0.755512
GEL 2.650391
GGP 0.756415
GHS 11.22504
GIP 0.756415
GMD 73.503851
GNF 8775.000355
GTQ 7.625892
GYD 209.119888
HKD 7.83685
HNL 26.68504
HRK 6.568104
HTG 130.583803
HUF 306.820388
IDR 17826.3
ILS 2.95976
IMP 0.756415
INR 94.330504
IQD 1310
IRR 1375000.000352
ISK 125.530386
JEP 0.756415
JMD 157.959917
JOD 0.70904
JPY 161.30504
KES 129.403801
KGS 87.450384
KHR 4010.00035
KMF 429.503794
KPW 900.00035
KRW 1527.650383
KWD 0.30793
KYD 0.833035
KZT 487.855928
LAK 22055.000349
LBP 89550.000349
LKR 333.641485
LRD 182.150382
LSL 16.405039
LTL 2.95274
LVL 0.60489
LYD 6.375039
MAD 9.225039
MDL 17.654036
MGA 4200.000347
MKD 53.732839
MMK 2099.727916
MNT 3581.295381
MOP 8.070939
MRU 40.060379
MUR 47.850378
MVR 15.450378
MWK 1737.000345
MXN 17.326504
MYR 4.137904
MZN 63.910377
NAD 16.403727
NGN 1360.440377
NIO 36.610377
NOK 9.680204
NPR 150.787532
NZD 1.741735
OMR 0.384983
PAB 0.999725
PEN 3.384039
PGK 4.38775
PHP 60.716504
PKR 278.325038
PLN 3.71375
PYG 6138.96617
QAR 3.640504
RON 4.568104
RSD 102.170373
RUB 73.103247
RWF 1464
SAR 3.74824
SBD 8.061424
SCR 13.683262
SDG 600.503676
SEK 9.57882
SGD 1.292404
SHP 0.746601
SLE 24.750371
SLL 20969.503664
SOS 571.503662
SRD 37.402504
STD 20697.981008
STN 21.4
SVC 8.747449
SYP 110.532098
SZL 16.403649
THB 32.890369
TJS 9.272075
TMT 3.5
TND 2.91175
TOP 2.40776
TRY 46.438204
TTD 6.779085
TWD 31.715038
TZS 2630.985038
UAH 44.909735
UGX 3638.520172
UYU 39.96965
UZS 12005.000334
VES 606.63266
VND 26310
VUV 118.773512
WST 2.751708
XAF 572.078806
XAG 0.015419
XAU 0.00024
XCD 2.70255
XCG 1.801643
XDR 0.703697
XOF 565.000332
XPF 104.250363
YER 238.603589
ZAR 16.458037
ZMK 9001.203584
ZMW 17.919703
ZWL 321.999592
  • CMSC

    0.0500

    22.37

    +0.22%

  • NGG

    -1.2400

    79.44

    -1.56%

  • CMSD

    0.0000

    22.29

    0%

  • GSK

    -1.4800

    50.67

    -2.92%

  • BP

    -1.0400

    39.1

    -2.66%

  • RIO

    -2.5900

    100.08

    -2.59%

  • BCE

    0.0000

    23.28

    0%

  • VOD

    -0.2300

    14.3

    -1.61%

  • RYCEF

    -0.0300

    18.4

    -0.16%

  • BTI

    -0.5800

    58.91

    -0.98%

  • AZN

    -2.9600

    174.93

    -1.69%

  • JRI

    0.0500

    12.67

    +0.39%

  • RELX

    -0.8300

    31.18

    -2.66%

  • BCC

    3.8500

    74.66

    +5.16%

  • RBGPF

    -0.5300

    60.61

    -0.87%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

O.Yip--ThChM